Solventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024. In the quarter to June 2026, revenue grew 2.22%, EPS grew 1.92%, free cash flow grew 144.1% and total debt fell 32.4%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow SOLV
Solventum Corporation (SOLV) Shares outstanding
Solventum Corporation's shares outstanding at the end of fiscal 2025 was $175.3M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $173.3M. Solventum Corporation ranks 11th of 50 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $175.3M | 0.92% |
| FY2024 | $173.7M | 0.58% |
| FY2023 | $172.7M | 0.00% |
| FY2022 | $172.7M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $173.3M | (1.25%) |
| Mar 2026 | $175.5M | 0.11% |
| Dec 2025 | $175.3M | (0.06%) |
| Sep 2025 | $175.4M | 0.11% |
| 10 more quarters | Free account |
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| AVTR Avantor, Inc. compare | $677.2M |
| BAX Baxter International Inc. compare | $518.0M |
| ALC Alcon compare | $488.7M |
| COO The Cooper Companies, Inc. compare | $193.4M |
| SOLV Solventum Corporation | $173.3M |
| ALGN Align Technology, Inc. compare | $71.5M |
| WST West Pharmaceutical Services, Inc. compare | $71.3M |
| ATR AptarGroup, Inc. compare | $64.2M |
| RGEN Repligen Corporation compare | $56.6M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Book value per share
- Revenue growth
- The full statement